Manulife (Manufacturers Life Insurance)’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.72M Buy
2025
Q2
$1.91M Buy
2025
Q1
$371K Sell
2024
Q4
$484K Sell
2024
Q3
$586K Buy
2024
Q2
$661K Sell
2024
Q1
$1.39M Sell
2023
Q4
$1.85M Buy
2023
Q3
$1.33M Buy
2023
Q2
$1.26M Buy
2023
Q1
$926K Buy
2022
Q4
$820K Buy
2022
Q3
$1.28M Sell
2022
Q2
$1.25M Buy
2022
Q1
$1.01M Buy